Navigation Links
Metamark Appoints Cornelius J. Merlini Chief Commercial Officer
Date:10/1/2013

CAMBRIDGE, Mass., Oct. 1, 2013 /PRNewswire/ -- Metamark Genetics, Inc., a leader in the discovery of molecular prognostic and diagnostic tests for cancer, today announced that Cornelius J. Merlini, former general manager of HealthTronics Laboratory Solutions (HLS), has been appointed Metamark's Senior Vice President and Chief Commercial Officer.  In August 2013, Metamark acquired HLS, a national uropathology laboratory, from Endo Health Solutions, Inc.  Mr. Merlini will report to Metamark President and Chief Executive Officer, Shawn M. Marcell, and will join the company's senior leadership team.

"We are pleased that Cornelius has joined Metamark.  His exceptional leadership, commercial acumen, and track record bringing paradigm-changing products to market have produced transformational business growth," said Mr. Marcell.  "Cornelius already is an established leader of Metamark's newly-acquired uropathology business, where he assembled a talented, dedicated team – including a specialized national field sales force.  This commercial team nicely complements Metamark's innovative research and development efforts, and will accelerate the launch of ProMark™, our novel prostate cancer prognostic test."

"Metamark's strong science engine fits perfectly with its new commercial and operational machine," said Mr. Merlini.  "ProMark™ could redefine the management of early stage prostate cancer and become a standard test sought by patients and ordered by urologists when making well-informed treatment decisions.  It is exciting to join a company that could change the way prostate cancer is treated." 

Mr. Merlini has over twenty-five years of life science experience across a wide array of functions and businesses.  Prior to HealthTronics Lab Solutions, Mr. Merlini was SVP, Commercial Operations at Cord Blood Registry, a market leader in cord blood stem cell banking.  He spent ten years with increasing marketing, management and franchise leadership responsibilities at Johnson & Johnson, where he served most recently as Worldwide Vice-President of the cardiovascular franchise for Johnson & Johnson's biopharmaceutical business.  Earlier, Mr. Merlini gained successful sales and sales leadership experience with Marion Laboratories (now Sanofi-Aventis). 

About Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based prognostic and diagnostic tests aimed at improving cancer care.  The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon and breast cancers.  In early 2014, Metamark plans to commercialize ProMark™ – its prostate cancer prognostic test – through its Cambridge, Massachusetts CLIA-certified laboratory.  For more information, please visit the company's Website at www.metamarkgenetics.com.  Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.


'/>"/>
SOURCE Metamark Genetics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
2. ACTUS Appoints New Members to Its Management Team
3. Immune Design Appoints Stephen R. Brady Chief Business Officer
4. DiaVacs, Inc. Appoints Orville Kolterman, M.D. As Chief Medical Officer
5. Sanomedics International Holdings, Inc. appoints new Chairman of the Board and installs new Director of Business Development.
6. Solulink Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer
7. Cold Spring Harbor Laboratory Appoints Teri F. Willey to Accelerate Commercialization Efforts
8. Senn Chemicals Appoints New Chief Executive Officer
9. Novelda Appoints Alf-Egil Bogen as Chief Executive Officer to Lead the Company to the Next Level
10. Creabilis Appoints Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board
11. Alexander Proudfoot Appoints Executive Vice President for Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... Participants of this ... high-performance fume hood. Along with the advantages and disadvantages of ductless, filtered fume ... hoods in the laboratory. , Attendees will learn from an industry expert about ...
(Date:9/19/2017)... ... 2017 , ... The new and improved Oakton® pocket testers, from Cole-Parmer, stand ... with a new cap design that is versatile, functional and leakproof. They are ideal ... test water quality. , The Oakton pocket testers have many user-friendly and functional features. ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... is pleased to announce the recipients of its 2017 Science Student Award. The ... leadership qualities, and involvement with community service defray the costs of obtaining their ...
(Date:9/19/2017)... ... September 19, 2017 , ... Band-LOK, LLC, an orthopedic ... that two new patents have been allowed by the USPTO on the proprietary ... “We continue to explore additional clinically-relevant designs for both the implants and the ...
Breaking Biology Technology:
(Date:4/17/2017)... 17, 2017 NXT-ID, Inc. (NASDAQ: NXTD ... filing of its 2016 Annual Report on Form 10-K on Thursday ... ... available in the Investor Relations section of the Company,s website at ... website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
Breaking Biology News(10 mins):